13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q1 2024 · Filed April 15, 2024 · Accession 0001104659-24-047278
Total Value
$103.7M
Positions
1
Other Managers
1
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 10,405,668 | $103.7M | 100.00% |